Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
Acuitas Therapeuticsacuitastx.com · Low evidenceAcuitas Therapeutics is a biotechnology company that specializes in lipid nanoparticle (LNP) delivery systems for nucleic acid therapeutics. The company operates on a strategic partnership model, enabling partners to accelerate drug development from preclinical stages through commercialization with its globally validated LNP technology.
Parse Score